Concepedia

Matthew W. Dudley

MW

Statistics

Publications

13

Citations

771

H-Index

12

Active since

1990

Affiliations

AbbVie (United States)(Current)

Duke Medical Center

Northwestern University

University of Chicago

Erasmus MC Cancer Institute

Matthew W. Dudley is an author at AbbVie (United States) specializing in medicine, oncology, and pharmacology.

Publications per year

1990–2020

13

Publications

13

Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial

Véronique Dièras, Hyo S. Han, Bella Kaufman et al. · The Lancet Oncology · 2020 · 321 citations · Full text

Medicine, Oncology, Pharmacology +10

Activity and Accumulation of Cell Division-Promoting Phenolics in Tobacco Tissue Cultures

Rita Teutonico, Matthew W. Dudley, John D. Orr et al. · PLANT PHYSIOLOGY · 1991 · 83 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +17

Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study

Brian G. Czito, Dustin A. Deming, Gayle Jameson et al. · The Lancet. Gastroenterology & hepatology · 2017 · 76 citations

Medicine, Oncology, Pharmacotherapy +11

53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer

Rachel M. Hurley, Andrea E. Wahner Hendrickson, Daniel W. Visscher et al. · Gynecologic Oncology · 2019 · 74 citations · Full text

Medicine, Molecular Biology, Oncology +12

Vegetative/Parasitic Transition: Control and Plasticity in <i>Striga</i> Development

Christopher E. Smith, Matthew W. Dudley, David G. Lynn · PLANT PHYSIOLOGY · 1990 · 60 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +15

1–5 of 13